Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Women taking hormone replacement therapy (HRT) alongside semaglutide have seen even greater weight loss success, with ...
Unlocking weight loss success with semaglutide. In the ever-evolving landscape of weight management, a new player has emerged ...
When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...
She’d first heard of Wegovy, a GLP-1 made by Novo Nordisk, from a friend’s success story ... arrived in the mail. It was ...
OZEMPIC and other “weight loss” jabs have now been linked to ten deaths in the UK. There have also been 7,228 reports of ...
As a GLP-1 receptor agonist, semaglutide mimics ... cardiovascular risks. The success of Wegovy highlights a new path in ...
“A balanced diet will help fuel your body for long-term success, keeping you on track ... which leads to weight loss.
A DAD died after taking a weight loss jab for just a few weeks. Tim Ramsay, from South Australia, wanted to shed some pounds so he could confidently walk his daughter down the aisle. The ...
Altimmune, Inc.’s Pemvidutide shows promise as a dual-action treatment for obesity and MASLD/MASH, targeting weight ...
In today's saturated market, finding weight loss supplements that genuinely deliver results without unwanted side effects feels like searching for a needle in a haystack. But 2024 is reshaping the ...
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback